Denali Therapeutics shares owned by Handelsbanken Fonder AB
Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by Handelsbanken Fonder AB
from 13F filings
Historical chart of Handelsbanken Fonder AB investment in Denali Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Denali Therapeutics held by Handelsbanken Fonder AB consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Denali Therapeutics by Handelsbanken Fonder AB
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $513k | 24k | 21.46 |
| 2023-09-30 | $355k | 17k | 20.64 |
| 2023-06-30 | $508k | 17k | 29.53 |
| 2023-03-31 | $325k | 14k | 23.05 |
| 2022-12-31 | $392k | 14k | 27.80 |
| 2022-09-30 | $411k | 13k | 30.67 |
| 2022-06-30 | $394k | 13k | 29.40 |
| 2022-03-31 | $380k | 12k | 32.20 |
| 2021-12-31 | $803k | 18k | 44.61 |
| 2021-09-30 | $908k | 18k | 50.44 |
| 2021-06-30 | $1.4M | 18k | 78.44 |
| 2021-03-31 | $1.0M | 18k | 57.09 |
| 2020-12-31 | $1.2M | 14k | 83.76 |
| 2020-09-30 | $505k | 14k | 35.82 |
| 2020-06-30 | $341k | 14k | 24.18 |